Diffuse non-obstructive coronary artery disease: two clinical faces of the same disease-a case report

Matjaž Klemenc1, Gregor Budihna1, Igor Kranjec2

  • 1Department of Intensive Care Unit, General Hospital of Nova Gorica, Padlih borcev 13A, Šempeter pri Gorici 5290, Slovenia.

Insights

Coronary artery disease (CAD) often has a long preclinical phase. This case highlights how non-obstructive CAD can present with varied symptoms, requiring advanced diagnostics for proper management.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Coronary artery disease (CAD) frequently exhibits a prolonged preclinical stage, characterized by diffuse non-obstructive disease, stenoses, or thrombosis before clinical manifestation.
  • Understanding the diverse clinical presentations of non-obstructive CAD is crucial for timely diagnosis and intervention.

Observation:

  • A middle-aged male presented with a spectrum of chest pain symptoms, including atypical pain, severe retrosternal pain, and effort angina.
  • Diagnostic workup involved non-invasive testing, coronary angiography, intravascular imaging, and flow reserve assessments to characterize the coronary artery disease.

Findings:

  • Diffuse non-obstructive coronary artery disease can manifest with varied clinical symptoms, necessitating comprehensive evaluation.
  • Exercise stress testing can be a valuable initial tool for assessing effort angina.
  • Flow reserve testing differentiates diffuse from focal disease patterns, guiding therapeutic strategies.
  • Intravascular imaging provides critical insights into plaque morphology and risk features.

Implications:

  • Accurate diagnosis of diffuse non-obstructive CAD relies on a combination of clinical assessment and advanced imaging techniques.
  • Personalized treatment strategies, including risk factor modification, pharmacotherapy optimization, and percutaneous coronary intervention, are essential for managing patients with non-obstructive CAD.
  • These diagnostic and therapeutic approaches align with current best clinical practices for managing coronary artery disease.
Abstract